Swiss National Bank Xencor Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Xencor Inc stock. As of the latest transaction made, Swiss National Bank holds 120,000 shares of XNCR stock, worth $2.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,000

Previous 107,500 11.63%

Holding current value

$2.77 Million

Previous $2.03 Million 18.63%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$15.7 - $21.65 $196,250 - $270,625	12,500 Added 11.63%	120,000 $2.41 Million
Q4 2023 Feb 06, 2024	SELL	$16.53 - $21.42 $198,360 - $257,040	-12,000 Reduced 10.04%	107,500 $2.28 Million
Q3 2023 Nov 08, 2023	BUY	$20.08 - $25.39 $38,152 - $48,241	1,900 Added 1.62%	119,500 $2.41 Million
Q2 2023 Aug 09, 2023	SELL	$24.77 - $29.9 $131,281 - $158,470	-5,300 Reduced 4.31%	117,600 $2.94 Million
Q1 2023 May 10, 2023	SELL	$25.95 - $36.95 $365,895 - $520,995	-14,100 Reduced 10.29%	122,900 $3.43 Million
Q4 2022 Feb 08, 2023	BUY	$24.79 - $30.86 $71,891 - $89,494	2,900 Added 2.16%	137,000 $3.57 Million
Q3 2022 Nov 09, 2022	BUY	$24.62 - $32.44 $78,784 - $103,808	3,200 Added 2.44%	134,100 $3.48 Million
Q2 2022 Aug 09, 2022	BUY	$19.74 - $29.01 $128,309 - $188,565	6,500 Added 5.23%	130,900 $3.58 Million
Q1 2022 May 09, 2022	BUY	$26.68 - $41.63 $229,448 - $358,018	8,600 Added 7.43%	124,400 $3.32 Million
Q3 2021 Nov 08, 2021	BUY	$30.65 - $35.68 $24,520 - $28,544	800 Added 0.7%	115,800 $3.78 Million
Q2 2021 Aug 06, 2021	SELL	$34.33 - $44.68 $109,856 - $142,976	-3,200 Reduced 2.71%	115,000 $3.97 Million
Q1 2021 May 07, 2021	BUY	$40.81 - $53.88 $77,539 - $102,372	1,900 Added 1.63%	118,200 $5.09 Million
Q3 2020 Nov 09, 2020	BUY	$30.09 - $43.02 $57,171 - $81,738	1,900 Added 1.66%	116,300 $4.51 Million
Q2 2020 Aug 05, 2020	BUY	$27.76 - $33.42 $427,504 - $514,668	15,400 Added 15.56%	114,400 $3.71 Million
Q1 2020 May 08, 2020	BUY	$20.69 - $37.79 $28,966 - $52,906	1,400 Added 1.43%	99,000 $2.96 Million
Q4 2019 Feb 06, 2020	BUY	$32.75 - $41.43 $75,325 - $95,289	2,300 Added 2.41%	97,600 $3.36 Million
Q3 2019 Nov 12, 2019	BUY	$33.73 - $46.27 $33,730 - $46,270	1,000 Added 1.06%	95,300 $3.21 Million
Q2 2019 Aug 02, 2019	BUY	$29.6 - $40.93 $62,160 - $85,953	2,100 Added 2.28%	94,300 $3.86 Million
Q1 2019 May 10, 2019	BUY	$27.85 - $38.09 $94,690 - $129,506	3,400 Added 3.83%	92,200 $2.86 Million
Q4 2018 Feb 13, 2019	BUY	$32.39 - $42.05 $48,585 - $63,074	1,500 Added 1.72%	88,800 $3.21 Million
Q3 2018 Nov 08, 2018	BUY	$35.69 - $47.65 $71,380 - $95,300	2,000 Added 2.34%	87,300 $3.4 Million
Q1 2018 May 04, 2018	BUY	$21.18 - $33.78 $400,302 - $638,442	18,900 Added 28.46%	85,300 $2.56 Million
Q3 2017 Nov 03, 2017	BUY	$19.61 - $23.35 $1.3 Million - $1.55 Million	66,400	66,400 $1.52 Million

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.8M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.38B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Xencor Inc Transaction History